As a proudly Swiss company, we’re committed to proven products and guiding our partners with wise counsel
Leading our Aptissen team with her characteristic passion and delivering our mission to free the musculoskeletal world of pain.
Committed to reliable and flexible financial management in a dynamic environment.
Driving the messaging and positioning of our portfolio in our everchanging modern society towards our healthcare practitioners and consumers alike. Sales growth is the result of consistency and true collaboration with our global network.
VP Sales & Marketing
Fostering a culture of medical and scientific rigor and ethical behavior and representing the voice of the patient, ensuring that it is at the forefront of all our decisions.
VP Medical Affairs
Optimizing and maintaining our high standards globally across all processes and stakeholders from sourcing to delivery of our solutions.
Founded in 2013, we have come a long way in a short period of time
Launch of SynolisTM VA 40/80
European patent on crossover frequency and concentration
Spin off Anteis - Aptissen Creation
Subsidiary in Italy
Subsidiary in Poland
Launch of SynolisTM VA 80/160 – CE mark
Subsidiary in France
MDSAP (Canada – Brazil)
2020 Launch of Cartylis TM
Quality is paramount as we are dedicated to the well-being of each and every person benefiting from our products.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.